JPH0321544B2 - - Google Patents

Info

Publication number
JPH0321544B2
JPH0321544B2 JP62061790A JP6179087A JPH0321544B2 JP H0321544 B2 JPH0321544 B2 JP H0321544B2 JP 62061790 A JP62061790 A JP 62061790A JP 6179087 A JP6179087 A JP 6179087A JP H0321544 B2 JPH0321544 B2 JP H0321544B2
Authority
JP
Japan
Prior art keywords
reaction
ester
compound
acid
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62061790A
Other languages
English (en)
Japanese (ja)
Other versions
JPS632973A (ja
Inventor
Shinji Hashimoto
Matsuhiko Araya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS632973A publication Critical patent/JPS632973A/ja
Publication of JPH0321544B2 publication Critical patent/JPH0321544B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP62061790A 1979-03-27 1987-03-16 ２−アゼチジノン誘導体 Granted JPS632973A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910719 1979-03-27
GB7910719 1979-03-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP3950880A Division JPS55162794A (en) 1979-03-27 1980-03-26 Cephalosporin analog compound, its preparation, and medicine comprising it

Publications (2)

Publication Number Publication Date
JPS632973A JPS632973A (ja) 1988-01-07
JPH0321544B2 true JPH0321544B2 (en, 2012) 1991-03-22

Family

ID=10504169

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3950880A Granted JPS55162794A (en) 1979-03-27 1980-03-26 Cephalosporin analog compound, its preparation, and medicine comprising it
JP62061790A Granted JPS632973A (ja) 1979-03-27 1987-03-16 ２−アゼチジノン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP3950880A Granted JPS55162794A (en) 1979-03-27 1980-03-26 Cephalosporin analog compound, its preparation, and medicine comprising it

Country Status (4)

Country Link
US (2) US4339449A (en, 2012)
EP (2) EP0017138B1 (en, 2012)
JP (2) JPS55162794A (en, 2012)
DE (1) DE3068410D1 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3616695T1 (sl) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozan/tazobaktam za zdravljenje intrapulmonalnih okužb
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
MX387913B (es) 2013-03-15 2025-03-19 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH563396A5 (en, 2012) * 1970-06-05 1975-06-30 Ciba Geigy Ag
US3880833A (en) * 1970-10-27 1975-04-29 Ciba Geigy Corp Certain bis-(3-amino-2-oxo-1-azetidinyl)-disulfides
JPS4878158A (en, 2012) * 1972-01-31 1973-10-20
DE2343497A1 (de) * 1972-06-22 1975-03-13 Hoechst Ag Verfahren zur herstellung von 4-mercapto-azetidinonen-(2)
US3951951A (en) * 1974-10-11 1976-04-20 Beecham Group Limited Azetidinones
JPS5188955A (en, 2012) * 1975-01-30 1976-08-04
US4070477A (en) * 1975-12-08 1978-01-24 Ciba-Geigy Corporation 2-Penem compounds
US4364865A (en) * 1975-12-08 1982-12-21 Ciba-Geigy Corporation Bicyclic unsaturated thia-aza compounds and 4-acylthio azetidinone intermediates
US4147699A (en) * 1976-11-11 1979-04-03 Massachusetts Institute Of Technology β-Lactam precursors of penicillin and cephalosporin antibiotics
DE2714880A1 (de) 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB2022092B (en) * 1978-06-06 1983-02-23 Fujisawa Pharmaceutical Co Cephalosporin anaglogoues and processes for the preparation thereof

Also Published As

Publication number Publication date
EP0017138A3 (en) 1981-01-14
US4339449A (en) 1982-07-13
JPH0138792B2 (en, 2012) 1989-08-16
EP0017138B1 (en) 1984-07-04
DE3068410D1 (en) 1984-08-09
EP0017138A2 (en) 1980-10-15
JPS632973A (ja) 1988-01-07
EP0070575B1 (en) 1986-11-05
EP0070575A2 (en) 1983-01-26
JPS55162794A (en) 1980-12-18
US4497738A (en) 1985-02-05
EP0070575A3 (en) 1983-05-25

Similar Documents

Publication Publication Date Title
JPS59219292A (ja) 有機化合物
US4342760A (en) Cephalosporin analogues
EP0005889A1 (en) Process for the preparation of beta-lactam derivatives, the novel derivatives so obtainable and pharmaceutical compositions containing them
JPH0333712B2 (en, 2012)
KR870001291B1 (ko) 세팔로 스포린의 제조방법
EP0043546B1 (en) 7-oxo-cephalosporins and 6-oxo-penicillins, their analogues and process for their preparation
GB2049675A (en) Cephalosporin derivatives
US4399277A (en) 7-Amino-3-phosphonocephalosporanic acid compounds
HU195664B (en) Process for producing cepheme derivatives and pharmaceutical compositions containing them
JPS6027677B2 (ja) ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法
JPH0321544B2 (en, 2012)
JPH0369354B2 (en, 2012)
JPS61249989A (ja) ７−アミノ−３−プロペニルセフアロスポラン酸及びそのエステル
JPH02790A (ja) ７―［２―（２―アミノチアゾール―４―イル）―２―ヒドロキシイミノアセトアミド］―３―セフェム化合物の製造法
JPH0515692B2 (en, 2012)
JPS6341914B2 (en, 2012)
JPH0521912B2 (en, 2012)
JPS6351389A (ja) セフアロスポリン誘導体、その製造法及び抗菌活性組成物
JPH08183789A (ja) 新規なセフェム化合物の製造法
KR880001990B1 (ko) 페니실린과 세팔로스포린 화합물의 제조방법 및 이들의 제조에 사용한 새로운 중간체의 제조방법
JPH0234953B2 (en, 2012)
JP2004149412A (ja) ７−［２−（２−アミノチアゾール−４−イル）−２−低級アルコキシカルボニルメトキシイミノアセトアミド］−３−セフェム化合物の製造法
JPH0414117B2 (en, 2012)
JPH01110689A (ja) ２β−ハロゲノ置換メチルペニシリン誘導体の製造法
JPH051271B2 (en, 2012)